LGC Biosearch Technologies™ launches a groundbreaking nucleic acid extraction method, sbeadex™ Lightning

This weekend LGC Biosearch Technologies™ launches a groundbreaking nucleic acid extraction method, sbeadex™ Lightning at the International Plant and Animal Genome conference (PAG) in San Diego. This groundbreaking product rapidly delivers high-purity DNA in high-yields, typically achieving results in 5 minutes – from lysate to eluate – for both plant and animal samples.

This magnetic bead technology significantly reduces the extraction workflow from a 5-step process to a simple 3-step method of bind, wash and elute. This advancement will enable laboratories to save up to 40 minutes per sample and increase sample throughput by as much as 10 times compared to competitors.

With fewer protocol steps and more environmentally friendly chemistry, customers can expect a positive impact on their ecological and carbon footprints with a reduction in plastic consumption, hazardous waste, and packaging, as well as delivering cost savings on energy and shipping.

Dr Heiko Hauser, Head of Research & Development, Nucleic Acid Purification at LGC Biosearch Technologies and inventor of sbeadex Lightning said, “Over the last two years, our dedicated efforts have focused on accelerating the process of high-purity, high-yield DNA purification, addressing a critical bottleneck for our customers, particularly when using NGS downstream assays. This advancement holds immense value for a diverse user base ranging from ultra-high-throughput applications to single sample purification and extends to those developing products for future point-of-need testing. It not only significantly streamlines the purification protocol but also reduces the environmental footprint of magnetic bead-based DNA purifications.”

Hillary Sullivan, Vice President of Research & Development at LGC Biosearch Technologies said, “We have instilled a culture of strategic innovation amongst the talented scientific community at LGC Biosearch Technologies. sbeadex Lightning is one of the innovative products that has come out of this culture, with more to follow. LGC is committed to reducing our impact on the environment, while developing tools that researchers can use to rapidly advance plant and livestock genetics so that farmers across the globe can continue to feed the world. At LGC we are proud of our brilliant scientists and their passion to discover and deliver innovative products that support our purpose – Science for a Safer World.”


  • sbeadex Lightning delivers pure DNA with typical 260/280 ratios of 1.7-2
  • sbeadex Lightning magnetic bead-based chemistry enables automated high-throughput extraction and purification of high-quality nucleic acids from easy to challenging sample types and is highly flexible with regards to input volumes, workflow adaptation and optimisation.
  • sbeadex Lightning extraction suitable for use for downstream workflows including next generation sequencing and PCR.
  • For further information on the performance of sbeadex Lightning download our poster sbeadex-Lightning-PAG24.pdf

About LGC
LGC is a leading, global life science tools company providing mission-critical components and solutions into high-growth application areas across the human healthcare and applied market segments. LGC’s tools play a key role in customer workflows from discovery applications through to commercial manufacture and enable its customers to bring new diagnostics and therapies to market, optimise food production and optimise food production.

About LGC Biosearch Technologies
LGC Biosearch Technologies is the comprehensive genomics portfolio from LGC, providing products and services for genomic analysis that support mission critical applications for global customers in agrigenomics and human healthcare. We offer tools and technologies to accelerate sample preparation, amplification, cloning, expression, next generation sequencing (NGS), oligonucleotide synthesis, and nucleic acid chemistry. We collaborate with our customers by applying our expertise in NGS, genotyping, PCR, and qPCR to enable them to achieve more than they thought possible.

< | >